Corporate calendar for Monopar Therapeutics Inc. (MNPR): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, which is in phase...
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | $1.03B |
Stock Splits
| Date | Ratio |
|---|---|
| 2024-08-13 | 1:5 |
Price
| Price | $101.45 |
| Market Cap | $680M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AKBA · BCYC · CMPX · FDMT · FULC · GOSS · KALV
Explore sector: Healthcare · Biotechnology
More sections of MNPR: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks